US Stock MarketDetailed Quotes

CING Cingulate

Watchlist
  • 4.3600
  • +0.1600+3.81%
Close Nov 29 13:00 ET
  • 4.2914
  • -0.0686-1.57%
Post 17:01 ET
14.01MMarket Cap-100P/E (TTM)

Cingulate Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cingulate Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Cingulate Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 7 07:58 ET

  • 8-K: Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market

    Nov 7 07:48 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 13 08:17 ET

  • 8-K: Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved

    Aug 13 08:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data